Study of ORIC-101 in Combination With Anticancer Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pratik S. Multani, MD
ORIC Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford Cancer Institute
Palo Alto, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- University of Colorado - Ppds
Aurora, Colorado, United States
- Florida Cancer Specialists & Research Institute
Lake Mary, Florida, United States
- Florida Cancer Specialists & Research Institute
Sarasota, Florida, United States
- Oregon Health & Science University
Portland, Oregon, United States
- Tennessee Oncology Nash - Scri - Ppds
Nashville, Tennessee, United States
- Mary Crowley Cancer Research Centers - Medical City
Dallas, Texas, United States
- University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Next Oncology
San Antonio, Texas, United States
- University of Utah - Huntsman Cancer Institute - Ppds
Salt Lake City, Utah, United States
- Virginia Cancer Specialists, Pc
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 May 2019
- Primary completion
- 22 Sept 2022
- Completion
- 4 Dec 2023
- Last update posted
- 15 Dec 2023
- Registered enrollment
- 83
- Registry id
- NCT03928314
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.